Two Sigma Advisers’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-35,700
| Closed | -$3.26M | – | 2675 |
|
|
2025
Q2 | $3.26M | Sell |
35,700
-12,900
| -27% | -$1.25M | 0.01% | 905 |
|
|
2025
Q1 | $5.5M | Sell |
48,600
-13,300
| -21% | -$1.42M | 0.01% | 751 |
|
|
2024
Q4 | $6.54M | Sell |
61,900
-3,900
| -6% | -$418K | 0.02% | 611 |
|
|
2024
Q3 | $7.1M | Sell |
65,800
-4,900
| -7% | -$535K | 0.02% | 585 |
|
|
2024
Q2 | $7.67M | Sell |
70,700
-15,400
| -18% | -$1.82M | 0.02% | 618 |
|
|
2024
Q1 | $11.4M | Sell |
86,100
-5,800
| -6% | -$725K | 0.03% | 495 |
|
|
2023
Q4 | $11.2M | Sell |
91,900
-1,900
| -2% | -$212K | 0.03% | 483 |
|
|
2023
Q3 | $10.5M | Sell |
93,800
-202,500
| -68% | -$25.7M | 0.03% | 453 |
|
|
2023
Q2 | $43.1M | Sell |
296,300
-165,000
| -36% | -$22.4M | 0.11% | 196 |
|
|
2023
Q1 | $59.6M | Buy |
461,300
+226,500
| +96% | +$28.4M | 0.15% | 136 |
|
|
2022
Q4 | $29.9M | Buy |
234,800
+95,800
| +69% | +$11.1M | 0.08% | 238 |
|
|
2022
Q3 | $14.5M | Buy |
139,000
+5,400
| +4% | +$593K | 0.04% | 396 |
|
|
2022
Q2 | $14M | Buy |
133,600
+51,100
| +62% | +$6.06M | 0.04% | 406 |
|
|
2022
Q1 | $10.6M | Buy |
82,500
+39,652
| +93% | +$4.78M | 0.03% | 502 |
|
|
2021
Q4 | $5.29M | Buy |
42,848
+34,402
| +407% | +$4.5M | 0.01% | 740 |
|
|
2021
Q3 | $1.2M | Sell |
8,446
-1,204,894
| -99% | -$177M | ﹤0.01% | 1528 |
|
|
2021
Q2 | $189M | Buy |
+1,213,340
| New | +$197M | 0.5% | 47 |
|
|
2021
Q1 | – | Sell |
-4,944
| Closed | -$740K | – | 2751 |
|
|
2020
Q4 | $740K | Buy |
+4,944
| New | +$698K | ﹤0.01% | 1709 |
|
|
2020
Q3 | – | Sell |
-16,583
| Closed | -$1.92M | – | 2658 |
|
|
2020
Q2 | $1.92M | Sell |
16,583
-9,064
| -35% | -$1.04M | 0.01% | 1220 |
|
|
2020
Q1 | $2.52M | Sell |
25,647
-10,918
| -30% | -$1.43M | 0.01% | 993 |
|
|
2019
Q4 | $5.31M | Buy |
+36,565
| New | +$5.05M | 0.01% | 826 |
|
|
2018
Q4 | – | Sell |
-6,911
| Closed | -$882K | – | 2483 |
|
|
2018
Q3 | $882K | Sell |
6,911
-28,943
| -81% | -$3.44M | ﹤0.01% | 1552 |
|
|
2018
Q2 | $3.88M | Sell |
35,854
-504,597
| -93% | -$54.9M | 0.01% | 964 |
|
|
2018
Q1 | $57.2M | Sell |
540,451
-221,257
| -29% | -$25.7M | 0.16% | 176 |
|
|
2017
Q4 | $89.2M | Buy |
761,708
+679,195
| +823% | +$76.8M | 0.24% | 111 |
|
|
2017
Q3 | $9.38M | Sell |
82,513
-65,070
| -44% | -$7.51M | 0.03% | 584 |
|
|
2017
Q2 | $18.4M | Sell |
147,583
-155,350
| -51% | -$18.4M | 0.06% | 360 |
|
|
2017
Q1 | $35.9M | Buy |
+302,933
| New | +$34.3M | 0.12% | 220 |
|
|
2016
Q4 | – | Sell |
-44,361
| Closed | -$5.6M | – | 2471 |
|
|
2016
Q3 | $5.6M | Buy |
+44,361
| New | +$5.48M | 0.02% | 608 |
|
|
2016
Q1 | – | Sell |
-63,300
| Closed | -$6.3M | – | 2154 |
|
|
2015
Q4 | $6.3M | Sell |
63,300
-655,582
| -91% | -$64.1M | 0.04% | 395 |
|
|
2015
Q3 | $65.7M | Buy |
718,882
+121,271
| +20% | +$12.2M | 0.41% | 63 |
|
|
2015
Q2 | $63.4M | Buy |
+597,611
| New | +$66.1M | 0.47% | 44 |
|
|
2015
Q1 | – | Sell |
-61,023
| Closed | -$6.72M | – | 2452 |
|
|
2014
Q4 | $6.72M | Sell |
61,023
-79,413
| -57% | -$8.37M | 0.05% | 405 |
|
|
2014
Q3 | $13.7M | Sell |
140,436
-10,300
| -7% | -$1.01M | 0.1% | 238 |
|
|
2014
Q2 | $15.2M | Buy |
150,736
+114,433
| +315% | +$11.2M | 0.12% | 199 |
|
|
2014
Q1 | $3.33M | Buy |
36,303
+31,930
| +730% | +$2.94M | 0.03% | 566 |
|
|
2013
Q4 | $395K | Buy |
+4,373
| New | +$378K | ﹤0.01% | 1740 |
|
Other funds holding ZBH
Two Sigma Advisers's ZBH Position: Q3 2025 in Review
Two Sigma Advisers sold out of Zimmer Biomet (ZBH) in Q3 2025, closing a stake of 35,700 shares — an estimated $3.26M sold.
Two Sigma Advisers first reported a position in ZBH in Q4 2013 and held it in 37 quarters. The position peaked at $189M in Q2 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Two Sigma Advisers reported no remaining Zimmer Biomet position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 35,700 Zimmer Biomet shares in Q3 2025, an estimated $3.26M.
- Two Sigma Advisers first reported a position in Zimmer Biomet in Q4 2013 and held it in 37 quarters.
- Two Sigma Advisers's Zimmer Biomet position peaked at $189M in Q2 2021.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.